FR2944015B1 - NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME - Google Patents

NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME

Info

Publication number
FR2944015B1
FR2944015B1 FR0901611A FR0901611A FR2944015B1 FR 2944015 B1 FR2944015 B1 FR 2944015B1 FR 0901611 A FR0901611 A FR 0901611A FR 0901611 A FR0901611 A FR 0901611A FR 2944015 B1 FR2944015 B1 FR 2944015B1
Authority
FR
France
Prior art keywords
activatory
lightening
peptides
compositions containing
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901611A
Other languages
French (fr)
Other versions
FR2944015A1 (en
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0901611A priority Critical patent/FR2944015B1/en
Priority to PCT/FR2010/000281 priority patent/WO2010112713A2/en
Publication of FR2944015A1 publication Critical patent/FR2944015A1/en
Application granted granted Critical
Publication of FR2944015B1 publication Critical patent/FR2944015B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
FR0901611A 2009-04-02 2009-04-02 NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME Expired - Fee Related FR2944015B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0901611A FR2944015B1 (en) 2009-04-02 2009-04-02 NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME
PCT/FR2010/000281 WO2010112713A2 (en) 2009-04-02 2010-04-01 Novel proteasome-activating lightening peptides and compositions containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901611A FR2944015B1 (en) 2009-04-02 2009-04-02 NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME

Publications (2)

Publication Number Publication Date
FR2944015A1 FR2944015A1 (en) 2010-10-08
FR2944015B1 true FR2944015B1 (en) 2012-03-09

Family

ID=41509057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901611A Expired - Fee Related FR2944015B1 (en) 2009-04-02 2009-04-02 NOVEL PROTEASOME ACTIVATORY LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME

Country Status (2)

Country Link
FR (1) FR2944015B1 (en)
WO (1) WO2010112713A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024000088A1 (en) * 2022-06-27 2024-01-04 欧诗漫生物股份有限公司 Pearl-derived whitening polypeptide and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3100005B2 (en) * 1992-07-28 2000-10-16 雪印乳業株式会社 Human immunodeficiency virus infection / growth inhibitor
FR2864085B1 (en) * 2003-12-18 2010-09-17 Centre Nat Rech Scient NEW MODULATORS OF PROTEASOME
AU2005312435A1 (en) * 2004-12-10 2006-06-15 Philera New Zealand Limited Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions

Also Published As

Publication number Publication date
FR2944015A1 (en) 2010-10-08
WO2010112713A2 (en) 2010-10-07
WO2010112713A3 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
HK1144823A1 (en) Compositions and methods of using proislet peptides and analogs thereof
FR2944797B1 (en) PEPTIDE HYDROLYSATS ACTIVATORS OF PROTEASOME AND COMPOSITIONS CONTAINING SAME
SMT201600249B (en) WATER PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX BORATO- POLIOLO
DK1996621T3 (en) Antibodies to beta-amyloid peptide
HK1208686A1 (en) Aromatic-cationic peptides and uses of same
IL209136A (en) Compositions of peptides and processes of preparation thereof
BR112013030372A2 (en) compositions containing, methods involving, and uses of unnatural amino acid-linked dolastatin derivatives
EP2373679A4 (en) Mini-hepcidin peptides and methods of using thereof
BR112012005237A2 (en) use of ternary compositions
BR112013030362A2 (en) compositions containing, methods involving, and uses of unnatural amino acid-linked dolastatin derivatives
ZA201209561B (en) Compositions and methods related to protein a (spa) variants
DK2504353T4 (en) LIPOPEPTIDE COMPOSITIONS AND SIMILAR METHODS
IL219947A (en) Cyclic peptides and pharmaceutical compositions comprising them
EP2651411A4 (en) Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
EP2566880A4 (en) Aromatic-cationic peptides and uses of same
IL219470A0 (en) Compositions containing fractalknie-binding proteins and uses thereof
FR2940969B1 (en) NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND / OR PHARMACEUTICAL COMPOSITION CONTAINING SAME
BRPI1011434A2 (en) methods of analyzing peptide mixtures
BRPI0915233A2 (en) fruity odorant
FR2944798B1 (en) PEPTIDE HYDROLYSATS LIGHTENING PROTEASOME ACTIVATORS AND COMPOSITIONS CONTAINING SAME
EP1998792A4 (en) Methods and compositions related to cyclic peptide synthesis
FR2944016B1 (en) NOVEL PROTEASOME ACTIVATOR ANTI-AGING PEPTIDES AND COMPOSITIONS CONTAINING SAME
EP2270141A4 (en) Partial peptide of lacritin
FR2944018B1 (en) NOVEL PROTEASOME ACTIVATOR ANTI-AGING PEPTIDES AND COMPOSITIONS CONTAINING SAME
EP2637681A4 (en) Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20200108